BACKGROUND: The clinical benefit of the administration of aerosolised recombinant human DNase (rhDNase) on pulmonary function in patients with cystic fibrosis has already been demonstrated but the biochemical action of rhDNase on DNA in bronchial secretions in vivo has not yet been investigated. METHODS: Sputum was collected from 135 patients with cystic fibrosis before and during treatment with aerosolised rhDNase and examined to ascertain DNA concentration and length by colorimetric assay and densitometry of gel separated DNA. RESULTS: Treatment with rhDNase reduced the concentration and the size of extracellular DNA in the sputum. The median interquartile range of DNA length decreased from 0.5-2.6 kbp before treatment to 0.3-1.0 kbp during treatment. CONCLUSIONS: rhDNase was delivered to the secretions and was enzymatically active in vivo.
BACKGROUND: The clinical benefit of the administration of aerosolised recombinant human DNase (rhDNase) on pulmonary function in patients with cystic fibrosis has already been demonstrated but the biochemical action of rhDNase on DNA in bronchial secretions in vivo has not yet been investigated. METHODS: Sputum was collected from 135 patients with cystic fibrosis before and during treatment with aerosolised rhDNase and examined to ascertain DNA concentration and length by colorimetric assay and densitometry of gel separated DNA. RESULTS: Treatment with rhDNase reduced the concentration and the size of extracellular DNA in the sputum. The median interquartile range of DNA length decreased from 0.5-2.6 kbp before treatment to 0.3-1.0 kbp during treatment. CONCLUSIONS: rhDNase was delivered to the secretions and was enzymatically active in vivo.
Authors: R C Hubbard; N G McElvaney; P Birrer; S Shak; W W Robinson; C Jolley; M Wu; M S Chernick; R G Crystal Journal: N Engl J Med Date: 1992-03-19 Impact factor: 91.245
Authors: H J Fuchs; D S Borowitz; D H Christiansen; E M Morris; M L Nash; B W Ramsey; B J Rosenstein; A L Smith; M E Wohl Journal: N Engl J Med Date: 1994-09-08 Impact factor: 91.245
Authors: B W Ramsey; S J Astley; M L Aitken; W Burke; A A Colin; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; D V Schidlow Journal: Am Rev Respir Dis Date: 1993-07
Authors: A L Smith; G Redding; C Doershuk; D Goldmann; E Gore; B Hilman; M Marks; R Moss; B Ramsey; T Rubio Journal: J Pediatr Date: 1988-04 Impact factor: 4.406
Authors: Tim Holm Jakobsen; Maria van Gennip; Richard Kerry Phipps; Meenakshi Sundaram Shanmugham; Louise Dahl Christensen; Morten Alhede; Mette Eline Skindersoe; Thomas Bovbjerg Rasmussen; Karlheinz Friedrich; Friedrich Uthe; Peter Østrup Jensen; Claus Moser; Kristian Fog Nielsen; Leo Eberl; Thomas Ostenfeld Larsen; David Tanner; Niels Høiby; Thomas Bjarnsholt; Michael Givskov Journal: Antimicrob Agents Chemother Date: 2012-02-06 Impact factor: 5.191
Authors: Keith H Turner; Aimee K Wessel; Gregory C Palmer; Justine L Murray; Marvin Whiteley Journal: Proc Natl Acad Sci U S A Date: 2015-03-16 Impact factor: 11.205
Authors: Patrick R Secor; Lia A Michaels; Anina Ratjen; Laura K Jennings; Pradeep K Singh Journal: Proc Natl Acad Sci U S A Date: 2018-10-01 Impact factor: 11.205
Authors: Lori K Sanders; Wujing Xian; Camilo Guáqueta; Michael J Strohman; Chuck R Vrasich; Erik Luijten; Gerard C L Wong Journal: Proc Natl Acad Sci U S A Date: 2007-10-02 Impact factor: 11.205
Authors: Patrick R Secor; Johanna M Sweere; Lia A Michaels; Andrey V Malkovskiy; Daniel Lazzareschi; Ethan Katznelson; Jayakumar Rajadas; Michael E Birnbaum; Allison Arrigoni; Kathleen R Braun; Stephen P Evanko; David A Stevens; Werner Kaminsky; Pradeep K Singh; William C Parks; Paul L Bollyky Journal: Cell Host Microbe Date: 2015-11-11 Impact factor: 21.023
Authors: Iordana Shopova; Sandra Bruns; Andreas Thywissen; Olaf Kniemeyer; Axel A Brakhage; Falk Hillmann Journal: Front Microbiol Date: 2013-06-06 Impact factor: 5.640